Immediate Impact
59 standout
Citing Papers
Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
Works of Erin Reid being referenced
A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody–Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
2019
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Erin Reid | 667 | 521 | 188 | 62 | 888 | |
| Matthew Mei | 496 | 381 | 284 | 104 | 1.1k | |
| Tadashi Motoori | 486 | 615 | 147 | 70 | 1.0k | |
| Sridhar Chaganti | 581 | 417 | 101 | 58 | 895 | |
| Anamarija M. Perry | 560 | 849 | 310 | 53 | 1.1k | |
| Neil Kogut | 489 | 346 | 113 | 52 | 901 | |
| Ronit Gurion | 356 | 319 | 199 | 80 | 776 | |
| Paul J. Bröckelmann | 494 | 621 | 120 | 82 | 890 | |
| Brady Beltrán | 719 | 731 | 174 | 78 | 1.0k | |
| L Boudová | 333 | 466 | 154 | 55 | 1.0k | |
| Chaitra S. Ujjani | 599 | 471 | 226 | 89 | 822 |
All Works
Login with ORCID to disown or claim papers
Loading papers...